 | Up a level |
Babinsky, VN, Hannan, FM 
ORCID: 0000-0002-2975-5170, Gorvin, CM, Howles, SA, Nesbit, MA, Rust, N, Hanyaloglu, AC, Hu, J, Spiegel, AM and Thakker, RV
(2016)
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Journal of Biological Chemistry, 291 (20).
pp. 10876-10885.
Gorvin, CM, Hannan, FM ORCID: 0000-0002-2975-5170, Cranston, T, Valta, H, Makitie, O, Schalin-Jantti, C and Thakker, RV
(2018)
Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss-of-function Gα 11 mutation.
Journal of Bone and Mineral Research, 31 (01).
pp. 32-41.
Babinsky, VN, Hannan, FM ORCID: 0000-0002-2975-5170, Ramracheya, RD, Zhang, Q, Nesbit, MA, Hugill, A, Bentley, L, Hough, TA, Joynson, E, Stewart, M et al (show 9 more authors)
(2017)
Mutant mice with calcium-sensing receptor activation have hyperglycemia, that is rectified by calcilytic therapy.
Endocrinology, 158 (8).
pp. 2486-2502.